Literature DB >> 7315086

The binding of fibrinogen and fibrinogen degradation products to the erythrocyte membrane and its relationship to haemorheology.

M W Rampling.   

Abstract

A study has been made of the binding of fibrinogen to erythrocyte membranes. The amount of fibrinogen bound is found to be proportional to the concentration in the suspending phase (up to 10 g/l) and to be unaffected by other plasma proteins or calcium ions (up to normal concentrations). The binding is also unaffected by temperature (between 4 and 37 degrees C). However it is sensitive to both pH and ionic strength variation. A similar study of the major fibrinogen degradation products (FDP) produced by plasmin shows that these all bind to red cell membranes but by different amounts. A model based on these data is suggested for the positions of the binding regions on the fibrinogen and FDP molecules and is used to explain their influence on rouleaux formation and on the flexibility of the erythrocyte.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7315086

Source DB:  PubMed          Journal:  Acta Biol Med Ger        ISSN: 0001-5318


  8 in total

1.  Lytic resistance of fibrin containing red blood cells.

Authors:  Nikolett Wohner; Péter Sótonyi; Raymund Machovich; László Szabó; Kiril Tenekedjiev; Marta M C G Silva; Colin Longstaff; Krasimir Kolev
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-07       Impact factor: 8.311

Review 2.  Fibrinogen, red blood cells, and factor XIII in venous thrombosis.

Authors:  B L Walton; J R Byrnes; A S Wolberg
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

Review 3.  Red blood cells in thrombosis.

Authors:  James R Byrnes; Alisa S Wolberg
Journal:  Blood       Date:  2017-08-15       Impact factor: 22.113

4.  Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking.

Authors:  James R Byrnes; Cédric Duval; Yiming Wang; Caroline E Hansen; Byungwook Ahn; Micah J Mooberry; Martha A Clark; Jill M Johnsen; Susan T Lord; Wilbur A Lam; Joost C M Meijers; Heyu Ni; Robert A S Ariëns; Alisa S Wolberg
Journal:  Blood       Date:  2015-08-31       Impact factor: 22.113

5.  The Impact of Biophysical Properties of Erythrocytes on their Aggregation.

Authors:  Mohamed A Elblbesy; Maisa E Moustafa
Journal:  Int J Biomed Sci       Date:  2017-06

6.  ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats.

Authors:  Oliver A Garden; Linda Kidd; Angela M Mexas; Yu-Mei Chang; Unity Jeffery; Shauna L Blois; Jonathan E Fogle; Amy L MacNeill; George Lubas; Adam Birkenheuer; Simona Buoncompagni; Julien R S Dandrieux; Antonio Di Loria; Claire L Fellman; Barbara Glanemann; Robert Goggs; Jennifer L Granick; Dana N LeVine; Claire R Sharp; Saralyn Smith-Carr; James W Swann; Balazs Szladovits
Journal:  J Vet Intern Med       Date:  2019-02-26       Impact factor: 3.333

7.  Blood transfusions increase the risk for venous thromboembolism events following total joint arthroplasty.

Authors:  Noam Shohat; Leanne Ludwick; Graham S Goh; Matthew Sherman; Joseph Paladino; Javad Parvizi
Journal:  Sci Rep       Date:  2021-10-28       Impact factor: 4.379

Review 8.  Inflammogenesis of Secondary Spinal Cord Injury.

Authors:  M Akhtar Anwar; Tuqa S Al Shehabi; Ali H Eid
Journal:  Front Cell Neurosci       Date:  2016-04-13       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.